Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

New biological classification of ovarian cancer

A thesis from The Sahlgrenska Academy in Sweden shows that it might be possible to predict with great probability which women with ovarian cancer will survive the disease before painful treatment with antineoplastic agents. A better prognosis would considerably improve the quality of life of patients since the treatment could be made more effective and thereby result in fewer side effects.

21 May 2008

Boost for cancer research in Leicestershire

A new approach to pain relief, investigation of a gene that triggers colorectal cancer and the prevention, early diagnosis and treatment of ovarian cancer are three research projects at the University of Leicester, which are to benefit from funding from the Leicestershire and Rutland charity Hope Against Cancer.

21 May 2008

Breast cancer gene a culprit in prostate cancer

Australian researchers have discovered that a mutated version of the BRCA-2 gene known to lead to breast and ovarian cancer, is also a culprit in prostate cancer in men.

20 May 2008

Discovery of new cell targets for preventing growth of breast and other tumors

Researchers at the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill have discovered new targets for cancer treatment aimed at blocking a key step in tumor progression.

23 Apr 2008

British volunteers needed to help bring cure for cancer closer

Researchers, who are in the process of developing a blood test that may diagnose breast cancer up to four years earlier than a mammogram, need the help of thousands of people living in the East Midlands.

21 Apr 2008

Yale researchers identify, characterize and clone ovarian cancer stem cells

Researchers at Yale School of Medicine have identified, characterized and cloned ovarian cancer stem cells and have shown that these stem cells may be the source of ovarian cancer’s recurrence and its resistance to chemotherapy.

17 Apr 2008

Drugs in the pipeline: new therapies that could change treatment strategies

The investigational drug AZD2171 (cediranib) may help shrink tumors and prolong survival of patients with a relatively common, aggressive type of brain cancer, according to results from a clinical trial conducted by Boston researchers.

16 Apr 2008

Increased life expectancy seen for patients with advanced cancers

A new study indicates that patients receiving treatments for late stage testicular, colorectal and ovarian cancer have increased life expectancy, resulting from the proportion of patients cured or by prolonging survival among non-cured patients.

13 Apr 2008

Prevention of osteoporosis might lie in vitamin D levels

Sixty-year-old Darlene Yates has had two hip replacements, a knee replacement and this past year shattered her left femur while she was walking in her neighborhood.

10 Apr 2008

Salivary diagnostics

Accuracy, convenience, and non-invasiveness are the most critical characteristics for any diagnostic tool.

7 Apr 2008

Roswell Park Cancer Institute awarded three-years funding for ovarian cancer vaccine

The Ovarian Cancer Research Fund has awarded a $900,000 research grant to Kunle Odunsi, MD, Department of Gynecologic Oncology, and his colleagues at Roswell Park Cancer Institute (RPCI) to collaborate on developing a promising vaccine to unleash the power of the immune system against cancer.

7 Apr 2008

Replacing absent microRNAs could make tumors less invasive, more treatable

One group of small, non-coding RNA molecules could serve as a marker to improve cancer staging and may also be able to convert some advanced tumors to more treatable stages, report a University of Chicago-based research team in the April 1, 2008, issue of the journal Genes & Development.

1 Apr 2008

MicroRNAs, EMT and cancer progression

In the April 1 issue of G&D, a research team led by Dr. Marcus Peter (University of Chicago) identifies the microRNA miR-200 as both a powerful indicator and regulator of the epithelial phenotype of cancer cells.

1 Apr 2008

Hairdressers at an increased risk for cancers

According to the World Health Organisation (WHO), hair dyes and other chemicals place hairdressers at an increased risk for cancer.

31 Mar 2008

MRI's high false positive rate has little impact on women's choice of preventive mastectomy

Magnetic resonance imaging (MRI) falsely detects breast cancer in five out of every six positive scans according to new research into the use of MRI for women with a high, inherited risk of developing the disease.

26 Mar 2008

Neuronal regulators offer potential targets for cancer

Being too brainy can be a bad thing in a junior high cafeteria, where the social hierarchy favors other traits. "Braininess" also causes problems for cells.

20 Mar 2008

Family communication impacts attitude about genetic counseling/testing for breast cancer

Whether or not relatives talk about the family's history of cancer significantly impacts attitudes and knowledge about genetic counseling and testing for those at moderate risk of developing breast cancer, according to a new preliminary study presented today at the American Society for Preventive Oncology meeting in Bethesda, Md.

19 Mar 2008

New clues to prevent spread of ovarian cancer

A drug that blocks production of an enzyme that enables ovarian cancer to gain a foothold in a new site can slow the spread of the disease and prolong survival in mice, according to a study by researchers from the University of Chicago Medical Center, but only if the drug is given early in the disease process.

14 Mar 2008

Specialized hospital care associated with better survival in Dutch ovarian cancer patients

Dutch ovarian cancer patients who were treated at a semispecialized or specialized hospital survived longer than those treated at a general hospital, according to a study published online March 11 in the Journal of the National Cancer Institute .

12 Mar 2008

Recurrent low-grade carcinoma of the ovary less responsive to chemo than more common ovarian cancers

Recurrent low-grade serous carcinoma, a rare type of ovarian cancer, is less sensitive to chemotherapy and therefore more difficult to treat than more common high-grade ovarian cancers, according to researchers from The University of Texas M. D. Anderson Cancer Center.

11 Mar 2008